AzTrials
AzTrials

Vaccination; InfectionNCT06048406

Effect of Health Education on Promoting Influenza Vaccination Health Literacy

A study testing Health education in people with Vaccination; Infection and Influenza, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this cluster randomized controlled trial is to evaluate the effect of health education interventions on influenza vaccination rates and health literacy in primary school students in the city of Dongguan in China. Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Vaccination; Infection, Influenza
What is being tested?
Health education
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,036 participants
Where
1 siteChina
Study dates
11 Sep 2023to 30 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Primary school students within the age range of 7-12 years.
  • Students and their parents who voluntarily agree to participate in the study and provide signed informed consent.
  • Permanent residents of Dongguan City who are expected to complete the project without transferring schools during the study period.

Who cannot join

  • Individuals with contraindications to influenza vaccination, who have recently received an influenza vaccination, diagnosed with influenza or confirmed as influenza-like cases at the commencement of the study.
  • Unwilling to participate in the project.

Trial locations and contacts

1 site in 1 country.

Chen Jingyi, Master contact

+86-13602477650

jychen0501@163.com

China1 site, 1 recruiting
  • Dongguang Center for Disease Control and Prevention

    Dongzhoucun, Guangdong, 510000

    Lin Xu, PhD, +8613602477650, xulin27@mail.sysu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Effect of Health Education on Promoting Influenza Vaccination Health Literacy Among Primary School Students

The goal of this cluster randomized controlled trial is to evaluate the effect of health education interventions on influenza vaccination rates and health literacy in primary school students in the city of Dongguan in China.

Individuals aged 7 to 12 years who are in grades 4-5 in primary schools in Dongguan will be enrolled. 20 primary schools will be randomly selected, with half designated as intervention group schools and the remaining half as control group schools. The intervention group will receive a monthly health education intervention focused on influenza vaccination for 5 months, while the control group will continue with their routine school health education for 5 months.

Researchers will compare the differences in influenza vaccination rates and influenza vaccination health literacy levels between the intervention and control groups after 5 months to see if health education can promote influenza vaccination health literacy among primary school students.

Read the detailed description

Introduction: Influenza is a major public health threat, and vaccination is the most effective prevention method. However, vaccination coverage remains suboptimal. Low health literacy regarding influenza vaccination may contribute to vaccine hesitancy. This study aims to evaluate the effect of health education interventions on influenza vaccination rates and health literacy.

Methods and analysis: This cluster randomized controlled trial will enroll 3036 students in grades 4-5 from 20 primary schools in Dongguan City, China. Schools will be randomized to an intervention group receiving influenza vaccination health education or a control group receiving routine health education. The primary outcome is influenza vaccination rate. Secondary outcomes include health literacy levels, influenza diagnosis rate, influenza-like illness incidence, and vaccine protection rate. Data will be collected through questionnaires, influenza surveillance, and self-reports at baseline and study conclusion.

Ethics and dissemination: Ethical approval has been sought from the Ethics Committee of the School of Public Health, Sun Yat-sen University. Findings from the study will be made accessible to both peer-reviewed journals and key stakeholders.

Being tested
Health education
Keywords
health education, health literacy, schools, China
Medical subject headings
Infections, Influenza, Human, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health educationCombination product

    The intervention group will receive a health education intervention focused on influenza vaccination literacy, while the control group will continue with their standard school health education without any additional intervention. An influenza vaccination health education including topics such as the importance of influenza vaccination, benefits of vaccination, and vaccination methods, will be developed and reviewed by an expert group. The package for the intervention group will include educational activities, distribution of promotional materials, vaccination services, and distribution of vaccination souvenirs.

Study groups in NCT06048406
Study groupRoleWhat they receive
InterventionExperimentalThe intervention group will receive a monthly health education intervention focused on influenza vaccination literacy for 5 months.
Receives: Combination Product: Health education
ControlNo interventionThe control group will continue with their routine school health education for 5 months.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. influenza vaccination rate

    he influenza vaccination rate will be calculated as the number of vaccinated individuals divided by the total number of individuals, multiplied by 100%.

    Measured: Within 20 weeks from enrollment

Secondary outcomes (4)
  1. influenza vaccination health literacy level

    Regarding the influenza vaccination health literacy level, each correct answer for the health literacy research questionnaire will be scored as one point, with incorrect answers receiving no points.

    Measured: Within 20 weeks from enrollment

  2. influenza incidence

    The influenza incidence will be calculated as the number of individuals diagnosed with influenza divided by the total number of individuals, multiplied by 100%

    Measured: Within 20 weeks from enrollment

  3. influenza vaccine protection rate

    The influenza vaccine protection rate will be calculated as the difference between the incidence rate in unvaccinated individuals and the incidence rate in vaccinated individuals, divided by the incidence rate in unvaccinated individuals, multiplied by 100%.

    Measured: Within 20 weeks from enrollment

  4. influenza-like illness incidence

    The ILI incidence will be calculated as the number of ILI cases divided by the total number of participants, multiplied by 100%.

    Measured: Within 20 weeks from enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start11 Sep 2023
  3. Primary completion30 Jun 2024 (estimated)
  4. Study completion30 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
3,036 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06048406
Sponsor's protocol ID
SunYat-senU20230908
Status last verified
Feb 2024
First submitted
8 Sep 2023
Last updated
21 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chen J, Xie W, Huang X, Huang A, Lu T, Zhang R, Xiao J, He S, Wang J, Xu L. Impact of multifaceted health education on influenza vaccination health literacy in primary school students: a cluster randomized controlled trial. BMC Med. 2025 Jun 4;23(1):333. doi: 10.1186/s12916-025-04156-1.

    PubMed 40468328
  • Xie W, Xiao J, Chen J, Huang H, Huang X, He S, Xu L. Impact of health education on promoting influenza vaccination health literacy in primary school students: a cluster randomised controlled trial protocol. BMJ Open. 2024 Apr 12;14(4):e080115. doi: 10.1136/bmjopen-2023-080115.

    PubMed 38609315

Questions about this trial

What is this clinical trial studying?

A study testing Health education in people with Vaccination; Infection and Influenza, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lin Xu, PhD (86-20-87335523, shellylxu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

influenza vaccination rate (time frame: Within 20 weeks from enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06048406, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in